[LGND] YoY Quarter Result on 30-Jun-2010 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
05-Aug-2010
Financial Year
2010
Quarter
30-Jun-2010 [#Q2]
Profit Trend
QoQ- 89.71%
YoY- 83.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 9,580 5,742 7,463 5,838 7,594 4,804 1,410 37.58%
PBT 3,804 -3,728 -773 335 -4,476 -5,919 -11,911 -
Tax 110 338 141 625 -4,476 -1,030 -4,225 -
NP 6,091 -2,267 -914 -283 -1,668 -6,429 181 79.58%
Tax Rate -2.89% - - -186.57% - - - -
Total Cost 3,489 8,009 8,377 6,121 9,262 11,233 1,229 18.97%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin 63.58 -39.48 -12.25 -4.85 -21.96 -133.83 12.84 30.52%
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
EPS 0.30 -0.11 -0.05 -0.01 -0.09 -0.41 0.01 76.18%
EPS Diluted 0.30 -0.11 -0.05 -0.01 -0.09 -0.41 0.01 76.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.